Sarah J George Selected Research

RS-130830

8/2006

Effect of broad-spectrum matrix metalloproteinase inhibition on atherosclerotic plaque stability.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sarah J George Research Topics

Disease

16	Atherosclerotic Plaque (Atheroma) 01/2022 - 10/2005
14	Atherosclerosis 01/2022 - 07/2004
7	Rupture 01/2017 - 10/2005
5	Neointima 06/2017 - 06/2003
4	Aneurysm (Aneurysms) 09/2021 - 01/2017
3	Inflammation (Inflammations) 10/2017 - 04/2011
3	Infections 06/2017 - 05/2006
2	Stroke (Strokes) 01/2022 - 06/2010
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 03/2016
2	Vascular Diseases (Vascular Disease) 09/2007 - 07/2004
2	Neoplasms (Cancer) 07/2004 - 06/2002
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2004 - 06/2002
1	Coronary Disease (Coronary Heart Disease) 05/2022
1	Renal Insufficiency (Renal Failure) 01/2022
1	Retinoblastoma (Glioblastoma, Retinal) 01/2022
1	Vascular Remodeling 01/2019
1	Congenital Heart Defects (Congenital Heart Defect) 01/2018
1	Right Ventricular Hypertrophy 01/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Pulmonary Hypertension 01/2018
1	Hyperplasia 10/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Abdominal Aortic Aneurysm 01/2017
1	Myocardial Infarction 09/2011
1	Necrosis 04/2011
1	Hypoxia (Hypoxemia) 04/2011
1	Acute Kidney Injury (Acute Renal Failure) 04/2011
1	Carotid Artery Injuries 02/2011
1	Melanoma (Melanoma, Malignant) 06/2002
1	Carcinogenesis 06/2002

Drug/Important Bio-Agent (IBA)

7	ApolipoproteinsIBA 09/2021 - 05/2006
6	Cadherins (E-Cadherin)IBA 12/2017 - 02/2009
6	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 10/2005
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2009
4	Apolipoproteins E (ApoE)IBA 09/2021 - 05/2006
4	Tissue Inhibitor of Metalloproteinase-3IBA 01/2017 - 06/2002
3	Cyclin D1IBA 01/2022 - 07/2004
3	Metalloproteases (Metalloproteinases)IBA 01/2017 - 06/2009
3	Tissue Inhibitor of Metalloproteinase-1IBA 02/2016 - 06/2003
3	Tissue Inhibitor of MetalloproteinasesIBA 02/2016 - 06/2002
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2022 - 01/2022
2	Angiotensin IIIBA 09/2021 - 01/2017
2	CollagenIBA 01/2017 - 06/2009
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 04/2011
2	Tissue Inhibitor of Metalloproteinase-2IBA 02/2016 - 05/2006
2	beta CateninIBA 09/2007 - 07/2004
1	Biological ProductsIBA 01/2022
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	Caspase 3 (Caspase-3)IBA 01/2022
1	Pharmaceutical PreparationsIBA 09/2021
1	Galectin 3 (LGALS3)IBA 01/2020
1	Long Noncoding RNAIBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Wnt-5a ProteinIBA 01/2019
1	Contractile ProteinsIBA 01/2018
1	CateninsIBA 06/2017
1	locked nucleic acidIBA 01/2017
1	MicroRNAs (MicroRNA)IBA 01/2017
1	ElastinIBA 01/2017
1	MetalsIBA 03/2016
1	Phenobarbital (Luminal)FDA Link 09/2011
1	Endothelins (Endothelin)IBA 04/2011
1	SodiumIBA 04/2011
1	Vasoconstrictor AgentsIBA 04/2011
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2011
1	Endothelin-1 (Endothelin 1)IBA 04/2011
1	Interleukin-18 (Interleukin 18)IBA 04/2011
1	Endothelin A ReceptorIBA 04/2011
1	salicylhydroxamic acid (SHAM)IBA 04/2011
1	Adenosine Triphosphate (ATP)IBA 04/2011
1	Adenosine (Adenocard)FDA LinkGeneric 04/2011
1	sitaxsentanIBA 04/2011
1	Peptides (Polypeptides)IBA 03/2011
1	Wnt4 ProteinIBA 02/2011
1	RNA (Ribonucleic Acid)IBA 02/2011
1	LipidsIBA 06/2009
1	Cytochalasin DIBA 02/2007
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2007
1	Sirolimus (Rapamycin)FDA Link 02/2007
1	Matrix Metalloproteinase InhibitorsIBA 08/2006
1	RS-130830IBA 08/2006
1	EnzymesIBA 08/2006
1	Catalytic RNA (Ribozymes)IBA 07/2004
1	Matrix Metalloproteinase 13IBA 07/2004
1	R-cadherinIBA 07/2004
1	Collagen Type IV (Type IV Collagen)IBA 06/2003

Therapy/Procedure

3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 05/2022 - 10/2017
3	Therapeutics 12/2020 - 06/2002
2	Ligation 01/2022 - 09/2011
2	Stents 03/2016 - 07/2004
1	Length of Stay 01/2022
1	Carotid Endarterectomy 01/2019
1	Drug Therapy (Chemotherapy) 01/2017
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 04/2011
1	Injections 06/2002